Search Results 181-190 of 16436 for monoclonal antibody

  1. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  2. Cancer Clinical Trials - Medical Professionals

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  3. Bullous Pemphigoid Clinical Trials

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

  4. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety and tolerability of the combination of idelallisib with the monoclonal antibody BI ...

  5. Oncology (Medical) - Clinical trials - Mayo Clinic

    Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

  6. Expert Alert: What's on the horizon for multiple myeloma and other blood cancers - Mayo Clinic News Network

    The safety and efficacy of REGN5458, a monoclonal antibody, which has been used in people who already have been treated for multiple myeloma. Several ...

  7. New frontiers in the treatment of COPD - Mayo Clinic

    "There is now interest in determining if targeted monoclonal antibody treatment could reduce COPD exacerbation, says Dr. Dulohery Scrodin. Mayo Clinic's campus ...

  8. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies ... Patients who have a history of a severe hypersensitivity reaction to monoclonal antibody or pembrolizumab (MK-3475) ...

  9. Health Topics - Mayo Clinic News Network

    What's the latest on monoclonal antibody therapies to treat COVID-19? Adam Harringa. January 12, 2022. COVID-19. What is 'flurona' and why a Mayo Clinic expert ...

  10. Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Monoclonal antibodies, such as rituximab, can block cancer growth in difference ways. Some block the ability of cancer cells to grow and spread. Others find ...